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z.2011.12Abstract This represented study aims to evaluate the protective effects of two natural antioxi-
dants, taurine and/or ginseng and their mixture on lipid proﬁle and some parameters indicative
of myocardial status in streptozotocin-diabetic rats.
Adult male albino rats (Sprague Dawley strain) were divided into ﬁve groups, a control and four
experimental groups; each of them contains ﬁve rats. The experimental animals were injected (i.p)
with 40 mg/kg body weight of streptozotocin (STZ) daily for 2 successive days to induce diabetes.
The ﬁrst group of diabetic rats was considered as a diabetic group and left without treatment. The
second group was injected i.p with 500 mg/kg body weight of taurine daily for one month and
served as diabetic plus taurine group. In the third group, ginseng was given orally at a dose of
400 mg/kg body weight daily for the same previous period. The last group received both taurine
and ginseng treatments at the aforementioned doses and through the same routes for one month.
The results indicated that the administration of taurine or ginseng showed a remarkable ameliora-
tion in glucose, glycosylated hemoglobin (HbA1C), insulin and free T3 levels. The maximum amelio-
ration in the level of glucose, HbA1C, insulin and free T3 occurred in diabetic rats that received the
mixture of taurine and ginseng.Additionally, treatment of diabetic rats with two antioxidants induced
a signiﬁcant reduction in serum cholesterol, triglycerides and low density lipoprotein levels. The anti-
oxidants also displayed a signiﬁcant decrease in the activities of cardiac enzymes, aspartate amino-
transferase (AST), creatine kinase (CK), lactate dehydrogenase (LDH) and the levels of serum
endothelin-1 with a signiﬁcant elevation in the levels of serum total nitric oxide (TNO) in the diabetic
animals group.The results suggest that a combination treatment between taurine andginsengmight rep-
resent the treatment of patients with cardiovascular disease (CVD) which is related to diabetic disorder.
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Diabetes mellitus is characterized by hyperglycemia and long-
term complications affecting the eyes, kidneys, nerves and
blood vessels. Several earlier investigations have conﬁrmed
the role of oxidative stress in developmental diabetic-mediatedand hosting by Elsevier B.V. All rights reserved.
268 A.A.S. Salehdisorders, possibly via the formation of free radicals (Heiba-
shy, 2005; Nogichi, 2007; Manna et al., 2009).
Cardiovascular complications characterized by endothelial
dysfunction and accelerated atherosclerosis, are the leading
causes of morbidity and mortality associated with diabetes.
There is growing evidence that excessive generation of highly
reactive free radicals, largely due to hyperglycemia, causes oxi-
dative stress, which further exacerbates the development and
progression of diabetes and its complications (Laakso, 1999).
Diabetes mellitus can be chemically induced in animals by
the administration of either streptozotocin or alloxan (Like
and Rossini, 1976). Streptozotocin, a glucosamine-nitrosourea
compound obtained from Streptomyces achromogenes, is used
to induce insulin-dependent diabetes mellitus (IDDM) in ro-
dents. Streptozotocin produces cytotoxic effect on b-cells of is-
lets of langerhans of pancreas by interfering with glucose
transporter GLUT-2 and causes DNA damage either by alkyl-
ation or peroxynitrite formation (Turk et al., 2003). The DNA
strands breakage by streptozotocin activates poly (ADP-ri-
bose) polymerase (PARP) and causes ATP depletion, which
leads to cell death (Pieper et al., 1999).
Disturbance in lipid metabolism is so prominent that diabe-
tes has been called ‘‘more a disease of lipid than carbohydrate
metabolism’’ (Rawi et al., 1998). However, the severity of
hyperlipidemia associated with diabetes is dependent on the
severity of the disturbances in the carbohydrate metabolism
and the degree to which the disease is controlled (Betteridge,
1989). Because, glucose cannot be used effectively as a meta-
bolic fuel, the mobilization of energy reserves from fat stores
is enhanced, leading to elevated concentration of fatty acids,
glycerol and ketones in the blood (Taylor and Aguis, 1988).
Over 95% of all lipids transported in the blood are present
in lipid-protein or lipoprotein and such types were affected vig-
orously in diabetes (Osman and Kandil, 1991).
The pathogenesis of diabetes mellitus is managed by oral
administration of hypoglycemic drugs. However, these agents
have a number of side-effects. Natural antioxidants such as
amino acids (taurine) and herbs such as (ginseng) have been
used for medicinal purposes for centuries (Olajide et al., 1999).
Taurine is one of the most abundant sulfur containing ami-
no acids. It plays an important role in carbohydrate metabo-
lism, the hypoglycemic properties of taurine were ﬁrst
observed by Ackerman and Heinsen (1935). In addition, tau-
rine was shown by Kulakowski and Maturo (1984) to increase
glucose utilization in rats. These results suggested that the
hypoglycemia action of taurine on blood glucose level is due
to increased glucose uptake followed by increased glycogen
accumulation in liver and skeletal muscles. Several authors re-
ported that taurine has the ability to increase insulin stimu-
lated protein synthesis without altering the insulin binding of
cells (Heibashy, 2005; El-Nahrawy and Heibashy, 2011).
Moreover, taurine has been shown to inﬂuence serum lipid
levels by changing lipid metabolism in the liver. Taurine
caused a signiﬁcant hypocholesterolmic effect on rats, proba-
bly by enhancing the catabolism of cholesterol and reducing
the absorption of dietary cholesterol. Also, the addition of tau-
rine to high cholesterol diet produced a signiﬁcant reduction,
not only in serum total cholesterol and triglyceride levels,
but also in total liver cholesterol, lipid and triglyceride con-
tents (Heibashy, 2000, 2005).
Many studies reported that in ischemic heart disease failure,
taurine levels in the cytosol were reduced and the external tau-rine might play an important role as a regulator of cardiac
function (Heibashy, 2005; Heibashy and Abdel-Moniem,
2005). Ginseng (Panax. sp.) is valuable in Chinese medicine
and plays an important role in folk medicine in East Asia. Gin-
seng glycopeptides have pharmacological effects, e.g., immu-
nomodulatory, anti-tumor, anti-ulcer and hypoglycemic
activities. A previous study reported that ginseng contains
about 20 ginseng polysaccharides, all of which have anti-
hyperglycemic effects (Miyazaki, 1989).
Studies have also shown that ginseng can improve the im-
mune response in diabetic patients (Kiefer and Pantuso,
2003; Cho et al., 2006). Ginseng has been used to treat a wide
variety of diseases including anemia, insomnia with neurasthe-
nia, gastritis, blood pressure abnormalities, dyspepsia, over-
strain and fatigue due to decrease in blood coagulation and
cholesterol and sugar levels (Wesnes et al., 2000; Cho et al.,
2006).
Thus, the present study was carried out to investigate the
changes in carbohydrate and lipid metabolism associated with
disturbances in myocardia as a result of experimentally-in-
duced diabetes. Moreover, the current investigation explored
the possible role of taurine or/and ginseng as therapeutic
agents to encounter the complications of diabetes.
Material and methods
The experiments were carried out with male albino rats (Spra-
gue Dawley strain) weighing 200 ± 5 g. The animals were ob-
tained from Helwan, Cairo, Egypt. The animals were
acclimatized for two weeks prior the experiments. They were
fed to appetite on standard laboratory animal rodent feed
according to NRC (1977) and water was available for animals
ad libitum. They were housed in a well ventilated animal house
kept under standard managerial and environmental conditions
(12 h light/dark cycles at 25 ± 2 C).
Animals were divided into ﬁve groups, a control and four
experimental groups; each of them contained ﬁve rats. The
experimental animals were injected (i.p) with 40 mg streptozoto-
cin (STZ) (Sigma Chem. Co., St. Louis, MO, USA)/kg body
weight dissolved in citrate buffer (0.1 M, pH 4.5) freshly pre-
pared and injected within ﬁve minutes of preparation daily for
2 successive days to induce diabetes. This particular dose of
STZ is known to develop metabolic disorders similar to those
caused by diabetes mellitus. Blood samples were drawn with a
syringe from the tail vein after 24 h of the last injection of
STZ for glucose estimation and the animals having a blood glu-
cose level of more than 200 and less than 300 mg/dL were se-
lected for the study (Anjaneyulu and Ramarao, 2002) to
achieve resolving the complications accompanied with diabetes.
The ﬁrst group of diabetic rats was considered as a diabetic
group and left without treatment. Each rat of the second group
was injected i.p with 500 mg taurine (Sigma Chem. Co., St
Louis, MO, USA)/kg body weight for one month and served
as diabetic plus taurine group as described by Nanami et al.
(1996). The third group, received ginseng (MEPACO, Inshas,
Egypt) suspended in tap water orally at a dose of 400 mg/kg-
body weight daily for the same previous period. The last group
received both taurine and ginseng at the aforementioned doses
and through the same routes for one month. At the end of the
experimental period, rats were dissected under slight anesthe-
sia, blood samples were collected by heart puncture, centri-
fuged and the sera were separated and stored at 20 C.
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Serum glucose concentration was estimated by the enzymatic
method of Trinder (1969). Blood glycosylated hemoglobin
(HbA1C) was determined by the enzymatic method according
to Trivelli’s method (Trivelli et al., 1971). Estimation of serum
rat insulin levels were assayed according to the methods of
Marschner et al. (1974) using ELISA (Sandwich Immunoassay
Technique). The commercial kits were purchased from ALP-
CO (USA).
Estimation of serum hormonal proﬁle
Serum free triiodothyronine (FT3) and free thyroxin (FT4) lev-
els were estimated by a radioimmunoassay method kit using
solid phase component system according to Ekins (1978) and
Siegel et al. (1978). The kits were purchased from Phoenix
Co., USA.
Estimation of serum lipid proﬁle
Serum total cholesterol (Watson, 1960), triglycerides (Fossati
et al., 1982) and HDL–cholesterol (Freidewald et al., 1972)
were estimated enzymatically using commercial kits from Ran-
dox, Ltd., Co. (UK). LDL–cholesterol was calculated as per
Freidewald’s equation:
LDL–Chol: ¼ Total Chol: ½TG=5HDL–Chol::Determination of serum cardiac status
Serum activities of lactate dehydrogenase (LDH), creatine ki-
nase (CK) and aspartate aminotransferase (AST) were mea-
sured kinetically according to the method of Reitman and
Frankel (1957), Szasz et al. (1977) and Weisshaar et al.
(1975), respectively. The kinetical commercial kits were pur-
chased from Sclavo Bio-diagnostic Co. (Italy).
Moreover, the concentrations of serum endothelin-1 (Waki-
saka et al., 1996) and total nitric oxide (Green et al., 1982)
were assayed by ELISA (Sandwich Immunoassay Technique)
using commercial kits (IBL-Hamburg, Co., Germany).
Statistic analysis
The comparison between the effects of different antioxidant
nutrients on biochemical parameters recorded herein were sta-
tistically analyzed using analysis of variance (ANOVA) fol-
lowed by Duncan’s multiple range tests as described by
Snedecor and Cochran (1982).
Results and discussion
In the current work, the rat was used as a model for the induc-
tion of non-insulin dependent diabetes mellitus (NIDDM) by
the injection of the diabetogenic drug streptozotocin (STZ)
at a dose level of 40 mg/kg body weight/day for 2 successive
days (Nanami et al., 1996). In early studies, several authors re-
ported that administration of STZ to rats induced hyperglyce-
mia and hypoinsulinemia in rats through an accelerated rate of
gluconeogenesis (elevated level of hepatic phosphoprotein
tyrosine phosphate carboxykinase, pyruvate, carboxylase fruc-
tose 1,6 diphosphatase and glucose-6-phosphatase) and de-pressed rates of glycolysis and pentose shunt (reduced
quantity of glucokinase, pyruvate kinase and 6-phosphogluco-
nate dehydrogenase) (Pieper et al., 1999; Turk et al., 2003).
Moreover, the hyperglycemia in STZ-treated rats leads to
the formation of hydrogen peroxide, which subsequently gen-
erates free radicals such as O2 and OH. These reactive com-
pounds can cause peroxidation of lipids, resulting in the
formation of hydroperoxy fatty acids and endoperoxides
(Pushparaj et al., 2000). Also, Coskun et al. (2005) and Cemek
et al. (2008) reported that a considerable necrotic degeneration
was observed in the peripheral part of the islets of Langerhans
in diabetic rats, Okatomoto (1985) discussed the mechanism of
action of STZ by acting as alkylating agent to damage the
DNA of the pancreatic beta cell. The author also reported that
STZ decomposes to form carbonium ions that alkylate DNA
and decrease cellular nicotinamide adenine dinucleotide
(NAD) level which may adversely affect the beta cell by inter-
rupting respiratory enzyme activity leading to irreversible cel-
lular necrosis.
In agreement with these previously reported results, the cur-
rent study showed a signiﬁcant (p< 0.05) elevation in glucose,
glycosylated hemoglobin (HbA1C) levels and a signiﬁcant
(p< 0.05) decrease in the concentration of insulin in serum
(Table 1). These results are attributed to the destructive effect
of STZ on the beta cells of pancreatic islets which led to inhi-
bition of insulin synthesis and increased blood glucose level
due to reduced entry of glucose into peripheral tissues, muscles
and adipose tissue (Masashi and Olefsky, 1979), increased gly-
cogen breakdown (Gold, 1970) and increased hepatic glucose
output either by enhanced glycogenolysis and/or gluconeogen-
esis (Rawi et al., 1996).
Furthermore, glycosylated hemoglobin (HbA1C) is nor-
mally high in diabetic patients and can reﬂect their metabolic
control and is considered a useful method in this regard.
HbA1C is produced by non-enzymatic condensation of glucose
molecules with free amino acids on the globin component of
hemoglobin (Beissuenger et al., 1993). The high level of glucose
led to an elevation in HbA1C (Nathan, 1990). HbA1C is useful
in the demonstration of glycemic control over a period of 8–12
weeks, which is the life span of RBCS (Heibashy, 2005). Its
main disadvantage is that it is not known until now whether
stable HbA1C can undergo rapid changes induced by short
time variation in glucose concentration (Delnero et al.,
1990). Also, false higher results may be obtained from uremia
or acylated hemoglobin resulting from high aspirin doses, also
low results are obtained with short life span of RBCS as with
hemolytic anemia (Boucher et al., 1983).
Taurine is a considerably potent hypoglycemic agent.
Regarding its hypoglycemic effect, it was suggested that an
insulin receptor is the postulated site of action of taurine
(Kulakowski and Maturo, 1990), taurine enhances glycogene-
sis, glycolysis and glucose oxidation (Mozaffari et al., 1986),
ameliorates the hyperglycemia induced by STZ (El-Agousa
et al., 2000) and lastly it was also used as adjuvant therapy
in patients with IDDM (Elizarova and Nedosugova, 1996).
These results are in agreement with the present ﬁnding re-
ﬂected by reducing levels of glucose and HbA1C and the eleva-
tion of insulin concentration in rats treated with taurine for
one month (Table 1).
Ginseng has been shown to inhibit gastric secretion in rats
and to decrease glucose and maltose absorption in rats and hu-
mans. Also, ginseng was reported to slow digestion, so low lev-
Table 1 Effects of taurine or/and ginseng on serum glucose, insulin, FT3 and FT4 levels and HbA1C concentration in streptozotocin-
diabetic rats.
Treatment Groups Glucose (mg/dL) HbA1C (%) Insulin (ng/ml) FT3 (pg/ml) FT4 (ng/dL)
Control 112.63 ± 3.59A 4.88 ± 0.45A 1.66 ± 0.019A 0.82 ± 0.016A 0.43 ± 0.009
Diabetic 269.55 ± 6.41B 8.54 ± 0.79 B 0.34 ± 0.007B 0.49 ± 0.009B 0.42 ± 0.008
Diabetic + T 196.23 ± 4.72C 6.61 ± 0.63 C 0.62 ± 0.011C 0.64 ± 0.011C 0.43 ± 0.009
Diabetic + G 217.27 ± 5.16D 7.02 ± 0.70 D 0.44 ± 0.009D 0.52 ± 0.011C 0.43 ± 0.009
Diabetic + T+G 168.91 ± 4.39E 5.23 ± 0.52 E 0.98 ± 0.014E 0.71 ± 0.013D 0.43 ± 0.009
Values are expressed as means ± S.E.
A, B, C, D, E = means bearing different superscripts within the same row that differ signiﬁcantly (P< 0.05).
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which operate through delaying or inhibiting the absorption
of carbohydrates in the gut. The effect of ginseng in lowering
blood glucose level in STZ-diabetic rats is probably attributed
to the insulin like components present in this plant (Vuksan
et al., 2001).
Active components of ginseng that may have an important
mediating role in the hypoglycemic processes include its poly-
saccharide (ginsenans), peptidoglycan (panaxans), and ginse-
noside proﬁles. Most pharmacological actions of ginseng,
however, are attributed to the involvement of ginsenosides
(Kim et al., 2002). Moram (2001) stated that ginseng fractions
isolated from ginseng roots such as ginseng polysaccharides or
polypeptides reduced blood glucose level and stimulated the
release of insulin. They suggested that ginseng increases carbo-
hydrate utilization and promotes the aerobic oxidation course.
Moreover, Attele et al. (2002) suggested that the antidia-
betic action of ginseng fraction may be partially mediated
through a decrease in hepatic gluconeogenesis by suppressing
the activity of key glucogenic enzymes. Also, ginseng has been
shown to increase glucose-transporter-2 in the livers of normal
and hyperglycemic mice.
In agreement with these previously reported results, the cur-
rent study showed a remarkable amelioration in glucose, gly-
cosylated hemoglobin (HbA1C) and insulin levels (Table 1).
However, the maximum amelioration in the levels of glucose,
HbA1C and insulin occurred in diabetic rats which received
the mixture of taurine and ginseng. These results may be
attributed to the additive or complementary effects of the
hypoglycemic agents for taurine and ginseng.
In the current work, the reciprocal relationship between the
concentrations of thyroid hormones (FT3 and FT4) in serum
and hyperlipidemia is described. These results seemed to be
in complete accordance with earlier studies made by Long
et al. (1953) they observed that thyroid activity has an adverse
effect on all plasma lipids.Table 2 Effects of taurine or/ and ginseng on serum lipid proﬁle in
Treatment groups Triglyceride (mg/dL) Cholesterol (mg/dL
Control 61.14 ± 2.39A 54.33 ± 2.07A
Diabetic 129.77 ± 3.97B 97.58 ± 4.62B
Diabetic + T 83.57 ± 3.52C 76.91 ± 3.74C
Diabetic + G 102.63 ± 3.77D 80.87 ± 4.16D
Diabetic + T+G 72.18 ± 2.61E 65.26 ± 2.85E
Values are expressed as means ± S.E.
A, B, C, D, E = means bearing different superscripts within the same roThe choice of serum free T3 and free T4 as the best in vitro
tests of thyroid function was based on the following fact: serum
free T3 and free T4 concentrations may be expected to reﬂect the
actual thyroid status more than the total T3 (TT3) and total T4
(TT4) concentrations because of the dependence of TT3 and TT4
values on plasma protein binding which almost binds all thyroid
hormones liberated from the thyroid gland leaving free T3 and
free T4 relatively unchanged in healthy subjects.
From Table 1, a signiﬁcant (p< 0.05) decrease in the level
of free T3 was evoked in the diabetic group while, a numerical
change occurred in the level of free T4. These results may be
due to the conversion of T3 to T4 or/and conversion of reverse
T3 (rT3) to T4. The Free T3 is considered to be the major bio-
logic mediator of the thyroid function test. The obtained data
in the current investigation were conﬁrmed by several recent
researches (Heibashy et al., 2009)
By reviewing the data in Table 2, the data revealed a pro-
portional relationship between the severity of hyperlipidemic
effect of STZ and the hypoglycemic status of the experimental
animals. A mountain of research was done and all of them
pointed to marked elevation in all lipid fractions except
HDL–cholesterol which showed negative correlation with the
severity of diabetes (Nanami et al., 1996; You and Chang,
1998). The diabetic hyperlipidemia is attributed to the distur-
bance of hormonal regulation of glucose metabolism and lep-
tin level. The elevated level of serum triglycerides in diabetic
animals may be attributed to a decrease in the clearance and
production of the major transporters of endogenously synthe-
sized triglycerides (Abdel-Moneim, 1998). This decrease of
clearance was found to be due to the decrease in adipose tissue
lipoprotein lipase as demonstrated in human diabetics (Nikkila
et al., 1977) and a decrease in hepatic triglycerides lipase as
indicated in STZ-diabetic rats (Nakai et al., 1979). Also, the
expansion of cholesterol pool in diabetes was explained by
O’Meara et al. (1990) through the increased intestinal choles-
terol synthesis, and the diminished synthesis of bile salts duestreptozotocin-diabetic rats.
) HDL–cholesterol (mg/dL) LDL–cholesterol (mg/dL)
15.29 ± 0.86A 26.81 ± 1.29A
11.54 ± 0.59B 60.09 ± 2.11B
13.68 ± 0.68C 46.52 ± 1.68C
13.44 ± 0.67C 46.90 ± 1.69C
15.23 ± 0.83D 35.59 ± 1.42D
w that differ signiﬁcantly (P< 0.05).
Table 3 Effects of taurine or/and ginseng on serum cardiac enzyme activities and the levels of endothelin-1 and TNO in
streptozotocin-diabetic rats.
Treatment groups LDH (U/L) CK (U/L) AST (U/L) Endothelin-1 (pg/ml) TNO (lmol/L)
Control 235.11 ± 7.12A 92.56 ± 2.81A 121.54 ± 4.59A 0.38 ± 0.007A 54.27 ± 2.17A
Diabetic 387.42 ± 11.26B 174.03 ± 4.32B 197.66 ± 7.11B 0.81 ± 0.016B 28.39 ± 1.26B
Diabetic + T 303.55 ± 10.27C 112.67 ± 3.74C 158.83 ± 6.23C 0.61 ± 0.013C 38.61 ± 1.68C
Diabetic + G 305.61 ± 11.94C 110.94 ± 3.82C 171.04 ± 6.84D 0.69 ± 0.014D 35.59 ± 1.53D
Diabetic + T+G 271.06 ± 8.87D 98.51 ± 3.56D 140.23 ± 5.02E 0.55 ± 0.010E 45.48 ± 1.94E
Values are expressed as means ± S.E.
A, B, C, D, E = means bearing different superscripts within the same row that differ signiﬁcantly (P< 0.05).
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enzyme responsible for the catabolism of cholesterol to bile
acids. LDL–cholesterol elevation in the serum of diabetic rats
could be attributed to a diminished number of peripheral LDL
receptors or reduced LDL binding to its receptors (Betteridge,
1989; Osman and Kandil, 1991). So, the hyperlipidemic pat-
tern observed in this study after the induction of diabetes by
STZ was in accordance with the previously published litera-
ture. This pattern is called atherogenic pattern of hyperlipid-
emia due to its perception of arteriosclerosis (Davidson, 1998).
The treatment of diabetic rats with taurine induced a
marked decrease in lipid proﬁle except HDL–cholesterol which
exhibited a value higher than that recorded in STZ diabetic
animals (Table 2). A similar study found that oral taurine
administration lowered the serum cholesterol, triglyceride
and total lipid levels as well as liver phospholipid and lipid
contents in rats (Mochizuki et al., 1998). The authors attrib-
uted the reduction in liver triglyceride content to the inhibition
of diacylglycerol, acyl-CoA synthetase and diacylglycerol acyl-
transferase by taurine treatment. These results are in agree-
ment with those obtained by Heibashy (2000) and Heibashy
et al. (2009).
Taurine suppressed the increase in the concentration of ser-
um total cholesterol and triglycerides in hypercholesterolemic
stork-prone spontaneously hypertensive rats (Ogawa, 1996).
The authors suggested that the hypolipidemic effect of taurine
was partly due to the inhibition of cholesterol absorption in
the intestine. Besides this action, cholesterol elimination from
the body was also postulated as an important factor by which
taurine reduces tissues and serum cholesterol levels through
increasing the conversion of cholesterol to bile acid as a result
of enhancement of 7-a hydroxylase, the rate limiting enzyme of
hepatic cholesterol catabolism and its conjugation to bile acids
lately. Furthermore, it has been suggested that taurine may be
responsible for the increase of HDL, modiﬁcation cholesterol
synthesis in the liver or/and balance of each of the serum lipo-
protein fractions containing cholesterol (Heibashy, 2000).
Moreover, it is likely possible that chronic administration of
taurine may be responsible also for hypocholesterolemia by
the enhancement of LDL receptor binding in the liver (Kama-
ta et al., 1996).
Maximum amelioration occurred in the total cholesterol,
HDL, LDL and triglycerides of diabetic rats treated with the
mixture of taurine and ginseng. These results may be attrib-
uted to the powerful joint effects of both antioxidants which
also act as hypolipidemic agents.
It is a well-established fact that diabetes is a risk factor for
cardiovascular disease. While, microvascular complications of
diabetes include nephropathy and retinopathy, macrovascularcomplications resulting in atherosclerotic cardiovascular dis-
eases such as coronary artery disease, cerebrovascular disease
and peripheral vascular disease are the leading causes of death
in the diabetic population (Laakso, 1999). The Diabetes Con-
trol and Complications trial (1993) demonstrated that tight
control of blood glucose is effective in reducing clinical compli-
cations signiﬁcantly, but even optimal control of blood glucose
could not prevent complications suggesting that alternative
treatment strategies are needed. Since, numerous studies dem-
onstrated that oxidative stress, mediated mainly by hyperglyce-
mia-induced generation of free radicals contributes to the
development and progression of diabetes and related contribu-
tions, it became clear that ameliorating oxidative stress
through treatment with antioxidants might be an effective
strategy for reducing diabetic complications (Heibashy, 2005).
There was a signiﬁcant (p< 0.05) elevation in the activities
of cardiac enzymes (AST, CK and LDH) in diabetic rats group
(Table 3). These results may be due to the excessive myocardial
infraction as a result of free radical production, epigenetic gene
alteration and inhibition in the activity of total nitric synthase
(NOs) enzyme which led to a remarkable depletion in the con-
centration of total nitric oxide in the blood. Also, these
changes may be due to the increase in the level of serum endo-
thelin-1 accompanied with elevation in serum ADMA level
and appearance of hypertension and metabolic syndrome.
These results are in parallel with those obtained by Heibashy
(2005) and Karaca et al. (2010).
In the current work, the maximum improvement occurred
in cardiac status parameters, (AST), (CK) and (LDH) activi-
ties and the levels of serum endothelin-1 and TNO in the dia-
betic animals group which was treated with both taurine and
ginseng. These data may be due to the synergistic effects of
both antioxidants by improving their pharmadynamic and
pharmakinetic properties, so they are considered bio-tonic
agents. So, a combination of taurine and ginseng might repre-
sent the treatment of patients with cardiovascular diseases
(CVD) which is related to diabetic disorders.References
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